Prashanthi Vemuri1, Timothy G Lesnick2, Scott A Przybelski2, Mary Machulda3, David S Knopman4, Michelle M Mielke2, Rosebud O Roberts5, Yonas E Geda6, Walter A Rocca5, Ronald C Petersen4, Clifford R Jack1. 1. Department of Radiology, Mayo Clinic, Rochester, Minnesota. 2. Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota. 3. Department of Psychology, Mayo Clinic, Rochester, Minnesota. 4. Department of Neurology, Mayo Clinic, Rochester, Minnesota. 5. Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota4Department of Neurology, Mayo Clinic, Rochester, Minnesota. 6. Department of Psychology, Mayo Clinic, Rochester, Minnesota5Department of Psychiatry, Mayo Clinic, Scottsdale, Arizona6Department of Neurology, Mayo Clinic, Scottsdale, Arizona.
Abstract
IMPORTANCE: Intellectual lifestyle enrichment throughout life is increasingly viewed as a protective strategy against commonly observed cognitive decline in the older population. OBJECTIVES: To investigate the association of lifetime intellectual enrichment with baseline cognitive performance and rate of cognitive decline in an older population without dementia and to estimate the years of protection provided against cognitive impairment by these factors. DESIGN, SETTING, AND PARTICIPANTS: Prospective analysis of individuals enrolled from October 1, 2004, and in 2008 and 2009 in the Mayo Clinic Study of Aging, a longitudinal, population-based study of cognitive aging in Olmsted County, Minnesota. We studied 1995 individuals without dementia (1718 cognitively normal individuals and 277 individuals with mild cognitive impairment) who completed intellectual lifestyle enrichment measures at baseline and underwent at least 1 follow-up visit. MAIN OUTCOMES AND MEASURES: We studied the effect of lifetime intellectual enrichment by separating the variables into 2 nonoverlapping principal components: education/occupation score and mid/late-life cognitive activity based on self-report questionnaires. A global cognitive z score served as the summary cognition measure. Linear mixed-effects models were used to investigate the associations of demographic and intellectual enrichment measures with global cognitive z score trajectories. RESULTS: Baseline cognitive performance was lower in older individuals; individuals with lower education/occupation score, lower mid/late-life cognitive activity, and APOE genotype; and men (P < .001). The interaction between the 2 intellectual enrichment measures was significant (P < .03) such that the beneficial effect of mid/late-life cognitive activity on baseline cognitive performance was reduced with increasing education/occupation score. Only baseline age, mid/late-life cognitive activity, and APOE4 genotype were significantly associated with longitudinal change in cognitive performance from baseline (P < .05). For APOE4 carriers with high lifetime intellectual enrichment (75th percentile of education/occupation score and midlife to late-life cognitive activity), the onset of cognitive impairment was approximately 8.7 years later compared with low lifetime intellectual enrichment (25th percentile of education/occupation score and mid/late-life cognitive activity). CONCLUSIONS AND RELEVANCE: Higher education/occupation scores were associated with higher levels of cognition. Higher levels of mid/late-life cognitive activity were also associated with higher levels of cognition, but the slope of this association slightly increased over time. Lifetime intellectual enrichment might delay the onset of cognitive impairment and be used as a successful preventive intervention to reduce the impending dementia epidemic.
IMPORTANCE: Intellectual lifestyle enrichment throughout life is increasingly viewed as a protective strategy against commonly observed cognitive decline in the older population. OBJECTIVES: To investigate the association of lifetime intellectual enrichment with baseline cognitive performance and rate of cognitive decline in an older population without dementia and to estimate the years of protection provided against cognitive impairment by these factors. DESIGN, SETTING, AND PARTICIPANTS: Prospective analysis of individuals enrolled from October 1, 2004, and in 2008 and 2009 in the Mayo Clinic Study of Aging, a longitudinal, population-based study of cognitive aging in Olmsted County, Minnesota. We studied 1995 individuals without dementia (1718 cognitively normal individuals and 277 individuals with mild cognitive impairment) who completed intellectual lifestyle enrichment measures at baseline and underwent at least 1 follow-up visit. MAIN OUTCOMES AND MEASURES: We studied the effect of lifetime intellectual enrichment by separating the variables into 2 nonoverlapping principal components: education/occupation score and mid/late-life cognitive activity based on self-report questionnaires. A global cognitive z score served as the summary cognition measure. Linear mixed-effects models were used to investigate the associations of demographic and intellectual enrichment measures with global cognitive z score trajectories. RESULTS: Baseline cognitive performance was lower in older individuals; individuals with lower education/occupation score, lower mid/late-life cognitive activity, and APOE genotype; and men (P < .001). The interaction between the 2 intellectual enrichment measures was significant (P < .03) such that the beneficial effect of mid/late-life cognitive activity on baseline cognitive performance was reduced with increasing education/occupation score. Only baseline age, mid/late-life cognitive activity, and APOE4 genotype were significantly associated with longitudinal change in cognitive performance from baseline (P < .05). For APOE4 carriers with high lifetime intellectual enrichment (75th percentile of education/occupation score and midlife to late-life cognitive activity), the onset of cognitive impairment was approximately 8.7 years later compared with low lifetime intellectual enrichment (25th percentile of education/occupation score and mid/late-life cognitive activity). CONCLUSIONS AND RELEVANCE: Higher education/occupation scores were associated with higher levels of cognition. Higher levels of mid/late-life cognitive activity were also associated with higher levels of cognition, but the slope of this association slightly increased over time. Lifetime intellectual enrichment might delay the onset of cognitive impairment and be used as a successful preventive intervention to reduce the impending dementia epidemic.
Authors: R O Roberts; Y E Geda; D S Knopman; R H Cha; V S Pankratz; B F Boeve; E G Tangalos; R J Ivnik; W A Rocca; R C Petersen Journal: Neurology Date: 2012-01-25 Impact factor: 9.910
Authors: Yonas E Geda; Hillary M Topazian; Lewis A Roberts; Robert A Lewis; Rosebud O Roberts; David S Knopman; V Shane Pankratz; Teresa J H Christianson; Bradley F Boeve; Eric G Tangalos; Robert J Ivnik; Ronald C Petersen Journal: J Neuropsychiatry Clin Neurosci Date: 2011 Impact factor: 2.198
Authors: Andrea L C Schneider; A Richey Sharrett; Mehul D Patel; Alvaro Alonso; Josef Coresh; Thomas Mosley; Ola Selnes; Elizabeth Selvin; Rebecca F Gottesman Journal: J Am Geriatr Soc Date: 2012-09-26 Impact factor: 5.562
Authors: Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Walter A Rocca Journal: Am J Epidemiol Date: 2011-03-23 Impact factor: 4.897
Authors: Michael Crowe; Ross Andel; Nancy L Pedersen; Boo Johansson; Margaret Gatz Journal: J Gerontol B Psychol Sci Soc Sci Date: 2003-09 Impact factor: 4.077
Authors: Meghan B Mitchell; Cynthia R Cimino; Andreana Benitez; Cassandra L Brown; Laura E Gibbons; Robert F Kennison; Steven D Shirk; Alireza Atri; Annie Robitaille; Stuart W S Macdonald; Magnus Lindwall; Elizabeth M Zelinski; Sherry L Willis; K Warner Schaie; Boo Johansson; Roger A Dixon; Dan M Mungas; Scott M Hofer; Andrea M Piccinin Journal: J Aging Res Date: 2012-09-13
Authors: Phillip J Schulte; David O Warner; David P Martin; Atousa Deljou; Michelle M Mielke; David S Knopman; Ronald C Petersen; Toby N Weingarten; Matthew A Warner; Alejandro A Rabinstein; Andrew C Hanson; Darrell R Schroeder; Juraj Sprung Journal: Crit Care Med Date: 2019-08 Impact factor: 7.598
Authors: Kenneth M Langa; Eric B Larson; Eileen M Crimmins; Jessica D Faul; Deborah A Levine; Mohammed U Kabeto; David R Weir Journal: JAMA Intern Med Date: 2017-01-01 Impact factor: 21.873
Authors: P J Schulte; R O Roberts; D S Knopman; R C Petersen; A C Hanson; D R Schroeder; T N Weingarten; D P Martin; D O Warner; J Sprung Journal: Br J Anaesth Date: 2018-06-27 Impact factor: 9.166
Authors: Stefanie Schreiber; Jacob Vogel; Henry D Schwimmer; Shawn M Marks; Frank Schreiber; William Jagust Journal: Neurobiol Aging Date: 2016-01-30 Impact factor: 4.673